Global prostate cancer drugs market was valued at $2,713 million in 2010 and is estimated to grow at a CAGR of 11.4% and 6.8% from 2010 to 2015 and 2015 to 2020 respectively. Therapy-wise, hormonal therapy is dominating the global prostate cancer drugs market with 66% market share in 2010 and is expected to account for 53% market share in 2020.

Driving factors and opportunities responsible for the growth of global prostate cancer therapeutics market have been the launch of innovative drugs (such as Jevtana, Provenge and Zytiga); coupled with the increasing prostate cancer prevalence (CAGR of 7.2% from 2010-2020) and increasing old age male population (7.2% increase from 2000-2030 in male population above 65 years age). However, increasing drug pricing pressures in mature countries (U.S. and Western Europe) and low success rates of the prostate cancer drugs in clinical development phases (4% success rate) are restraining the market growth.

In 2010, Europe dominated the global prostate cancer drug market by accounting for 43% market share. However, share of Europe is estimated to decrease by 2% by 2020 due to increase of market size in Japan and emerging markets.

Major players in the market in 2010 include AstraZeneca PLC (U.K.), Sanofi-Aventis (France), Ipsen (France), Tolmar Inc (U.S.), Abbott (U.S.), Astellas Pharma Inc (Japan), Indevus Pharmaceuticals Inc (U.S.), Dendreon Corporation (U.S.), and Ferring Pharmaceuticals (Switzerland).

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com.

Note: An email containing the Login Details and Time of the Analyst Briefing will be sent to you soon after your registration.